Journals / Kocatepe Veteriner Dergisi / 2016 / Cilt: 9 - Sayı: 3

Epidermal Growth Factor

Epidermal Büyüme Faktörü

Pages
215–225
Publication Date
2016-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to summarize the structure, sources, receptor, effect mechanism, effects and for use in therapy of epidermal growth factor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epidermal growth factor is a growth factor in protein structure that stimulating division, differentiation, survival, proliferation, growth and migration of the cells which takes role in many physiological and pathological processes of the organism.
📊
Key Findings & Data:EGF exerts its effects through binding to EGFR mainly by activating MAPK, ERK 1/2, PI3K-Akt, PLC-γ, JAK/STAT intracellular signaling pathways.
💡
Conclusion & Impact:The aim of this review is to summarize the structure, sources, receptor, effect mechanism, effects and for use in therapy of epidermal growth factor.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Epidermal Büyüme Faktörü · Epidermal Büyüme Faktörü Reseptörü · Epidermal Growth Factor

Abstract

Epidermal growth factor is a growth factor in protein structure that stimulating division, differentiation, survival, proliferation, growth and migration of the cells which takes role in many physiological and pathological processes of the organism. EGF has anti-inflammatory, anti-apoptotic, neuroprotective and neurotrophic effects. Epidermal growth factor receptors are located on the cell surface of many tissues that include lung, stomach, duodenum, pancreas, kidney, pituitary gland, thyroid gland, mammary gland, ovary, uterus, placenta, cornea and glia. Platelets, macrophages, monocytes and fibroblasts are also source of epidermal growth factor. EGF exerts its effects through binding to EGFR mainly by activating MAPK, ERK 1/2, PI3K-Akt, PLC-γ, JAK/STAT intracellular signaling pathways. Epidermal growth factor exerts its effect mainly on the digestive, reproductive and nervous system. Epidermal growth factor administration especially in treatment of wounds has success because of its stimulating effect on growth and proliferation of fibroblasts, keratinocytes and vascular endothelial cells. The aim of this review is to summarize the structure, sources, receptor, effect mechanism, effects and for use in therapy of epidermal growth factor.

Özet

Epidermal büyüme faktörü, hücrelerin bölünmesi, farklılaşması, yaşaması, çoğalması, büyümesi ve hücre göçünü uyaran protein yapıda bir büyüme faktörü olup, organizmadaki pek çok fizyolojik ve patolojik süreçte rol almaktadır. EGF, anti-enflamatuar, anti-apoptotik, nörotrofik ve nöroprotektif etkilere sahiptir. Epidermal büyüme faktörü reseptörleri akciğer, mide, duodenum, pankreas, böbrek, hipofiz bezi, tiroid bezi, meme bezi, yumurtalık, uterus, plasenta, kornea ve gliya hücrelerinde bulunmaktadır. Trombositler, makrofajlar, monositler ve fibroblastlar da epidermal büyüme faktörü kaynağıdır. Epidermal büyüme faktörü, epidermal büyüme faktörü reseptörüne bağlanarak, MAPK, ERK 1/2, PI3K-Akt, PLC-γ, JAK/STAT hücre içi sinyalizasyon yolaklarını aktive ederek etki etmektedir. Epidermal büyüme faktörü etkilerini başlıca sindirim sistemi, üreme sistemi ve sinir sistemi üzerinde göstermektedir. Fibroblastların, kerotinisitlerin, vasküler endotel hücrelerinin büyümesini ve çoğalmasını uyarıcı etkisi nedeniyle, özellikle yaraların tedavisinde epidermal büyüme faktörü uygulamaları başarı sağlamaktadır. Bu derlemenin amacı, EGF’nin yapısı, kaynakları, reseptörü, etki mekanizması, etkileri ve tedavide kullanımını özetlemektir.

🔖

Cite This Article

YARIM, G. F., KAZAK, F. (2016). Epidermal Growth Factor. Kocatepe Veteriner Dergisi, Cilt: 9 - Sayı: 3, 215–225. https://ajindex.com/articles/124689

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Acosta JB, Savigne W, Valdez C, Franco N, Alba JS, del Rio A, López-Saura P, Guillén G, Lopez E, Herrera L, Férnandez-Montequín J. Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. Int Wound J. 2006; 3(3):232-239.
  2. Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I. EGF increases expression and activity of PAs in preimplantation rat embryos and their implantation rate. Reprod Biol Endocrinol. 2007; 5:4. Aguirre A, Dupree JL, Mangin JM, Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci. 2007; 10(8):990-1002.
  3. Altschuler LR, Parisi MN, Cageao LF, Chiocchio SR, Fernandez-Pol JA, Zaninovich AA. Epidermal growth factor stimulates thyrotropin secretion in the rat. Neuroendocrinology. 1993; 57(1):23-27.
  4. Aral İL, Güngör N, Oygür T, Cinel L. Epidermal Büyüme Faktörünün (EGF) Deri Allogreftleri Üzerine Olan Etkilerinin Histopatolojik olarak Araştırılması. GÜ Dişhek Fak Der. 1995; 12(1):47-53.
  5. Babül A, Gönül B, Özoğul C, Dinçer S, Erdoğan D, Pınar L, Çelebi N. EGF Accelerates Mice Skin Wound Healing, Proceed. 8thinler. Pharm. Technol. 1996; Symp. (IPTS-96), Sept. 9:1 Ankara-TURKEY. Bruder ED, Hoof JV, Young JB, Raff H. Epidermal growth factor and parathyroid hormone-related peptide mRNA in the mammary gland and their concentrations in milk: effects of postpartum hypoxia in lactating rats. Horm Metab Res. 2008; 40(7):446-453.
  6. Buret A, Olson ME, Gall DG, Hardin JA. Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits. Infect Immun. 1998; 66(10):4917-4923.
  7. Burling K, Seguin MA, Marsh P, Brinkman K, Madigan J, Thurmond M, Moon-Massat P, Mannis M, Murphy CJ. Effect of topical administration of epidermal growth factor on healing of corneal epithelial defects in horses. Am J Vet Res. 2000; 61(9):1150-1155.
  8. Caballero ME, Calunga J, Barber E, Cruz E, López-Saura P, Boix E, Berlanga J. Epidermal growth factor-mediated prevention of renal ischemia/reperfusion injury. Biotecnol Apl. 2000; 17:161-165.
  9. Carpenter G, Cohen S. Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol. 1976; 88(2):227-237. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987; 56:881-914.
  10. Carpenter G, Cohen S. Epidermal Growth Factor. Ann Rev Biochem. 1979; 68:194-216.
  11. Chabot JG, St-Arnaud R, Walker P, Pelletier G. Distribution of epidermal growth f